Deletion of Calhm2 alleviates MPTP-induced Parkinson's disease pathology by inhibiting EFHD2-STAT3 signaling in microglia
Theranostics · 2023
DOI: 10.7150/thno.83082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2023. Verfasst von Xuena Bo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center on Translational Neuroscience, College of Life & Environmental Science, Minzu University of China, Beijing, 100081, China. Hauptthemen laut MEDLINE: Parkinson Disease, Secondary, Calcium Channels. Die Arbeit wurde bisher 20-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center on Translational Neuroscience, College of Life & Environmental Science, Minzu University of China, Beijing, 100081, China.
- The Brain Science Center, Beijing Institute of Basic Medical Sciences, Beijing, 100850, China.
- School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.
Zitieren
APA
Bo, X., Xie, F., Zhang, J., Gu, R., Li, X., Li, S., Yuan, Z., & Cheng, J. (2023). Deletion of Calhm2 alleviates MPTP-induced Parkinson's disease pathology by inhibiting EFHD2-STAT3 signaling in microglia. Theranostics. https://doi.org/10.7150/thno.83082
Vancouver
Bo X, Xie F, Zhang J, Gu R, Li X, Li S, et al. Deletion of Calhm2 alleviates MPTP-induced Parkinson's disease pathology by inhibiting EFHD2-STAT3 signaling in microglia. Theranostics. 2023. doi:10.7150/thno.83082
BibTeX
@article{Bo2023,
author = {Bo, Xuena and Xie, Fei and Zhang, Jingdan and Gu, Runze and Li, Xiaoheng and Li, Shuoshuo and Yuan, Zengqiang and Cheng, Jinbo},
title = {Deletion of Calhm2 alleviates MPTP-induced Parkinson's disease pathology by inhibiting EFHD2-STAT3 signaling in microglia},
journal = {Theranostics},
year = {2023},
doi = {10.7150/thno.83082}
}
EUVIMED